Award recordCONTRACT

INTERCEPT PHARMACEUTICALS INC

PIID V797D6029E· VA Staff Offices· NAC FEDERAL SUPPLY SCHEDULE (36F797)· 6505 · DRUGS AND BIOLOGICALS· FY2016· $0 net obligations· UEI GHNKCLBJRMK7· NY

Description

INTERIM AGREEMENT UNDER FSS SCHEDULE 65 I B DRUGS, PHARMACEUTICALS,&HEMATOLOGY RELATED PRODUCTS

First action · last action
2016-06-22 · 2017-01-04
Transactions
3
First transaction's obligation
$0
Base + all options value (sum of deltas)
$25,000
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
999
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 3 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$1$0Base award · 2016-06-22 · this action $0 · running total $0Modification P00002 · 2016-12-12 · this action $0 · running total $0Modification P00001 · 2017-01-04 · this action $0 · running total $0
  • Base2016-06-22+$0= $0
  • Mod P000022016-12-12+$0= $0
  • Mod P000012017-01-04+$0= $0
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2016-06-22+$0$0INTERIM AGREEMENT UNDER FSS SCHEDULE 65 I B DRUGS, PHARMACEUTICALS,&HEMATOLOGY RELATED PRODUCTS
Mod P00002· OTHER ADMINISTRATIVE ACTION2016-12-12+$0$0EXTENSION.
Mod P00001· LEGAL CONTRACT CANCELLATION2017-01-04+$0$0INTERIM AGREEMENT UNDER FSS SCHEDULE 65 I B DRUGS, PHARMACEUTICALS,&HEMATOLOGY RELATED PRODUCTS

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI GHNKCLBJRMK7)

AwardOffice · PSC / listingNet obligationsFY
36E79725A0001NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2025
36F79724D0180NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS$0FY2024
36E79722A0011NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2022
36C24920F0531249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS$49,147FY2020
36C24719K0039247-NETWORK CONTRACT OFFICE 7 (36C247) · 6505 · DRUGS AND BIOLOGICALS$4,363FY2019
36C26119F0005261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS$26,401FY2019

Other recipients under 6505 from NAC FEDERAL SUPPLY SCHEDULE (36F797) (most recent first)

AwardRecipientOfficeNet obligationsFY
36F79726D058EREVOLUTION MEDICINES, INC.NAC FEDERAL SUPPLY SCHEDULE (36F797)$0FY2026
36F79726D0172LUNDBECK LLCNAC FEDERAL SUPPLY SCHEDULE (36F797)$0FY2026
36F79726D0195MILESTONE PHARMACEUTICALS USA, INC.NAC FEDERAL SUPPLY SCHEDULE (36F797)$0FY2026
36F79726D0165RECKITT BENCKISER LLCNAC FEDERAL SUPPLY SCHEDULE (36F797)$0FY2026
36F79726D0118OMEROS CORPORATIONNAC FEDERAL SUPPLY SCHEDULE (36F797)$0FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_IDV_V797D6029E_3600 · retrieved 2026-09-26.